Dr Paul McKenzie appointed as CSL’s new CEO
Australia’s most valuable manufacturing company CSL has appointed Dr Paul McKenzie as its new CEO replacing Paul Perreault who has been in the role for 10 years. Perreault navigated the global vaccine and blood products company through the Covid pandemic, as well as further globalising the business. McKenzie previously served as CSL’s chief operating officer,…
Details










